The first in a two-part conversation series, this article offers an insightful dialogue with Dr. Danielle Rankin -- an esteemed epidemiologist within the Centers for Disease Control and Prevention (CDC). The focus of this discussion is her recent research study on the alarming proliferation of New Delhi metallo-β-lactamase carbapenem-resistant Enterobacterales (NDM-CRE) across the United States,…
The healthcare sector is grappling with an escalating threat from an insidious germ that's proving tough to combat. Infections induced by NDM-producing carbapenem-resistant Enterobacterales (CRE), bacteria notorious for their ability to resist even our most potent antibiotics, have skyrocketed recently. A recent, peer-reviewed examination reveals as astounding 460 percent hike in such cases from 2019…
For over a decade, healthcare facilities in the United States have been grappling with the specter of carbapenem-resistant Enterobacterales (CRE). This group of bacteria has returned with a vengeance, thanks to the rise of the New Delhi metallo-β-lactamase-producing CRE (NDM-CRE), a formidable foe resistant to multiple therapeutic options.
The Centers for Disease Control and Prevention (CDC)…
The United States is witnessing an alarming surge in human infections stemming from drug-resistant bacteria, warns the Centers for Disease Control and Prevention (CDC). The CDC lab tests have uncovered a dramatic increase in instances of a bacterium known as NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE). This bacterium is a subset of the broader category of bacteria…
In the United States, a disturbing trend of antibiotic-resistant bacterial infections is gaining pace, necessitating an urgent call to action among infection prevention professionals. The Centers for Disease Control and Prevention (CDC) has warned of the increased occurrences of an antibiotic-resistant bacteria, known as NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE). This bacteria belongs to a broader class…
The U.S. Centers for Disease Control and Prevention (CDC) is raising significant health alarms related to a drastic surge in the infections from carbapenem-resistant Enterobacterales (CRE), often referred to as 'nightmare bacteria' known for its resistance to some of the most robust antibiotics available. Recent studies reveal that there has been a staggering 461 percent…
In recent years, the United States has observed a significant increase in infections caused by an extremely drug-resistant and high-risk bacterium, known as NDM-producing carpabenem-resistant Enterobacterales, or simply, NDM-CRE. According to a report released by the Centers for Disease Control and Prevention (CDC), there has been an alarming 460% surge in these infections between 2019…